"I wholeheartedly recommend Betsy Loop for the 2019 CURE® Extraordinary Healer® Award because that is a perfect description of her: extraordinary and a healer of the body, of the mind and, most important, of the spirit. She deserves to be recognized as a very special person and nurse — and one I have been blessed to know," wrote Carol Schumacher.
The Food and Drug Administration has approved the PI3K inhibitor Piqray (alpelisib) for the treatment of postmenopausal women, and men, with HR-positive, HER2-negative, PIK3CA-mutated, advanced or metastatic breast cancer following progression on or after an endocrine-based regimen.
Cancer survivor Joanne Edwards talks with CURE® about the profound gratitude she felt when she received a ‘Caring and Sharing’ basket from a charity organization, and shares how their generosity made her want to pay it forward to other survivors.
More Than Friends chairperson Elise Bourne-Busby talked about her breast cancer journey and the inspiration for the Latino/Caribbean/American initiative that is dedicated to servicing cancer survivors.
In this episode of CURE® Talks Cancer, we spoke with an advocate who is raising awareness around the recent controversy surrounding a certain type of breast implant that is causing a rare type of lymphoma.